NIRTEK

Nirtek was formed to prevent heart attacks and save lives by detecting unstable coronary plaques using a patented technology known as near infrared autofluorescence (NIRAF) so they can be treated before they lead to major adverse cardiovascular events, the leading cause of death worldwide.

Also known as: Nirtek Pty Ltd

Registration numbers: 98 131 762 948 (W)

Primary location: Melbourne Australia